1707.TW · GKB
Taiwan · RS rating 7 · As of 2026-10-08
| Price | 85.40 TWD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 12 / 37 / 11 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 11 / 16 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +33.3% |
| Sales growth Q/Q | +6.0% |
| Distance from 52-week high | +34.3% |
| Market cap (USD) | $395.3M |